2018 Formulary Update
|
|
- Lindsay Ford
- 5 years ago
- Views:
Transcription
1 MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January This document outlines all of the updates to the formulary as of. Medicare beneficiaries must use network pharmacies to access their prescription drug benefit. Benefits, formulary, pharmacy network, premiums, and/or copayments/coinsurance may change on January 1, If you would like to receive this material in another format or language, or have questions about this formulary, please call us at (TTY 711). We re available: October 1 February 14 February 15 September 30 8 a.m. to 8 p.m., 7 days a week 8 a.m. to 8 p.m., Monday Friday During non-business hours, your call will be answered by our automated phone system. A representative will return your call the next business day. Part D Coverage Decisions and Appeals A coverage decision is a decision we make about your benefits and coverage, or about the amount we will pay for your drugs. Here are examples of coverage decisions you may ask us to make about your Part D drugs: Asking us to cover a Part D drug that is not on our list of covered drugs (i.e., the formulary attached) Asking us to waive a restriction on our coverage for a drug (such as limits on the amount of the drug you can receive) Asking to pay a lower cost-sharing amount for a covered, non-preferred drug You ask us whether a drug is covered for you and whether you satisfy any applicable coverage rules. (For example, your drug is on our list of covered drugs, but we require you to get approval from us before we will cover it for you). You ask us to pay for a prescription drug you already bought. This is a request for a coverage decision about payment. If you disagree with a coverage decision we have made, you can appeal our decision. If you would like to file an appeal or request an exception to a recent coverage determination, see your Evidence of Coverage for detailed instructions. Y0086_PTD281 Accepted NENY_R12071_ HPMS Approved Formulary File Submission ID , Version 12
2 If you disagree with our decision to remove or change the tiering structure of the drugs on our list of covered drugs (i.e., the formulary), you may file a grievance with us. You can do so by calling us at (TTY 711). You may also send your grievance to us in writing to: BlueShield of Northeastern New York PO Box 5204 Binghamton, NY Whether you call or write, you should contact customer service right away if you intend to file a grievance. Grievances must be filed within 60 calendar days of. See your Evidence of Coverage for detailed instructions. Adacel(Tdap syringe 2 Lf-( T3 Adolescent/Adult)(PF) 5mcg)-5Lf/0.5 adapalene-benzoyl peroxide ml gel with pump % PA (TOPICAL RETINOID PRODUCTS) Aliqopa recon soln 60mg T5 PA (B VS D); LA aminophylline solution 250mg/10 ml Amnesteem capsule 10mg Amnesteem capsule 20mg Amnesteem capsule 40mg aripiprazole solution 1mg/mL T5 Baxdela recon soln 300mg T5 Benlysta auto-injector 200mg/mL T5 Benlysta syringe 200mg/mL T5 bortezomib recon soln 3.5mg T5 PA (B VS D) Bosulif tablet 400mg T5 QL (30 PER 30 ; (BOSULIF) Bydureon BCise auto-injector 2mg/0.85 ml T3 QL (4 PER 28 ; PA (GLUCAGON-LIKE PEPTIDE-1 AGONISTS) Calquence capsule 100mg T5 QL (60 PER 30 ; (CALQUENCE); LA 2
3 carvedilol phosphate capsule, ER 80mg multiphase 24 hr caspofungin recon soln 50mg T5 PA (B VS D) dactinomycin recon soln 0.5mg PA (B VS D) dapsone gel 5% desogestrel-ethinyl tablet mg estradiol doxycycline hyclate tablet 75mg doxycycline hyclate tablet 150mg efavirenz capsule 50mg eletriptan HBr tablet 20mg QL (18 PER 28 eletriptan HBr tablet 40mg QL (18 PER 28 estradiol tablet 10mcg ethynodiol diacetateethinyl tablet 1-35mg-mcg estradiol fluoxetine tablet 60mg fosamprenavir tablet 700mg T5 Glatiramer syringe 20mg/mL T5 QL (30 PER 30 ; PA (COPAXONE) glatiramer syringe 40mg/mL T5 QL (12 PER 28 ; PA (COPAXONE) Glyxambi tablet 10-5mg T3 QL (30 PER 30 Glyxambi tablet 25-5mg T3 QL (30 PER 30 haloperidol decanoate solution 100mg/mL (1 ml) Havrix (PF) suspension 720 Elisaunit/0.5 T3 ml Havrix (PF) syringe 1,440Elisa T3 unit/ml Humalog Junior KwikPen insulin pen, half-unit 100unit/mL T3 ST (RAPID-ACTING INSULIN-PST) Idhifa tablet 100mg T5 QL (30 PER 30 ; (IDHIFA); LA Idhifa tablet 50mg T5 QL (60 PER 30 ; (IDHIFA); LA Isibloom tablet mg 3
4 Jadenu Sprinkle granules in packet 90mg T5 PA (EXJADE/JADENU) Jadenu Sprinkle granules in packet 360mg T5 PA (EXJADE/JADENU) Jadenu Sprinkle granules in packet 180mg T5 PA (EXJADE/JADENU) Juluca tablet 50-25mg T5 Kadcyla recon soln 160mg T5 (KADCYLA) Klor-Con packet 20mEq T1 lanthanum tablet,chewable 500mg lanthanum tablet,chewable 1,000mg lanthanum tablet,chewable 750mg Lartruvo solution 10mg/mL (19 ml) T5 PA (B VS D); LA Levonorgestrel/ethinyl estradiol Lupron Depot-Ped (3 month) tablets,dose month pack, mg-20 mcg/0.15 mg-25 mcg 4 syringe kit 30mg T5 (LEUPROLIDE (LONG ACTING)) Lynparza tablet 100mg T5 (LYNPARZA) Lynparza tablet 150mg T5 (LYNPARZA) meropenem recon soln 1gram mesalamine tablet,delayed release (DR/EC) 1.2gram methotrexate sodium solution 25mg/mL (10 ml) (PF) methylphenidate HCl capsule,er biphasic 30mg morphine syringe 5mg/mL PA (B VS D) QL (400 PER 30 moxifloxacin drops 0.5% Mylotarg recon soln 4.5 mg (1 mg/mlinitial T5 conc) PA (B VS D); LA Nerlynx tablet 40mg T5 LA Opdivo solution 100mg/10 ml T5 (OPDIVO) oseltamivir suspension for 6mg/mL reconstitution
5 oxaliplatin recon soln 100mg PA (B VS D) paroxetine mesylate capsule 7.5mg (menopausal symptoms) QL (30 PER 30 peg 3350-electrolytes recon soln gram piperacillintazobactam recon soln 2.25gram potassium chloride solution 2mEq/mL prasugrel tablet 10mg prasugrel tablet 5mg Prevymis solution 240mg/12 ml T5 Prevymis solution 480mg/24 ml T5 Prevymis tablet 240mg T5 Prevymis tablet 480mg T5 ProFeno tablet 600mg Radicava piggyback 30mg/100 ml T5 Rituxan concentrate 10mg/mL T5 (RITUXAN) scopolamine base patch 3 day 1mg over 3 days sevelamer carbonate tablet 800mg Soliqua 100/33 insulin pen 100 unit- T3 33mcg/mL Stelara solution 45mg/0.5 ml T5 testosterone solution in metered pump w/app 30 mg/actuation(1.5 ml) timolol maleate drops, once daily 0.5% tramadol tramadol tramadol tablet, ER multiphase 24 hr tablet, ER multiphase 24 hr tablet, ER multiphase 24 hr 300mg (matrix delivery) Treanda recon soln 25mg T5 5 PA (STELARA) PA (TOPICAL TESTOSTERONE PRODUCTS) QL (30 PER 30 ; PA (LONG ACTING OPIOIDS) 200mg QL (30 PER 30 ; PA (LONG ACTING OPIOIDS) 100mg QL (30 PER 30 ; PA (LONG ACTING OPIOIDS) PA (B VS D)
6 Trelegy Ellipta blister with device mcg T3 QL (60 PER 30 Trisenox solution 2mg/mL T5 PA (B VS D) Twinrix (PF) syringe 720 Elisa unit-20 T3 mcg/ml Vaqta (PF) suspension 50unit/mL T3 Vaqta (PF) suspension 25unit/0.5 ml T3 Verzenio tablet 50mg T5 QL (240 PER 30 ; New Starts Only PA (VERZENIO); LA Verzenio tablet 100mg T5 QL (120 PER 30 ; New Starts Only PA (VERZENIO); LA Verzenio tablet 150mg T5 QL (80 PER 30 ; (VERZENIO); LA Verzenio tablet 200mg T5 QL (60 PER 30 ; (VERZENIO); LA vigabatrin powder in packet 500mg T5 LA Vyxeos recon soln mg T5 PA (B VS D) Xatmep solution 2.5mg/mL T5 PA (B VS D) Xuriden granules in packet 2gram T5 Zenpep capsule,delayed 20,000-63,000- T3 release(dr/ec) 84,000 unit Altavera (28) tablet mg Alunbrig tablet 90mg T5 QL (60 PER 30 ; (ALUNBRIG) Alunbrig tablet 180mg T5 QL (30 PER 30 ; (ALUNBRIG) Alunbrig tablets,dose pack 90 mg (7)-180 mg (23) atazanavir capsule 150mg atazanavir capsule 200mg atazanavir capsule 300mg T5 6 T5 QL (30 PER 30 ; (ALUNBRIG)
7 Eliquis tablets,dose pack 5mg (74 tabs) T3 Enskyce tablet mg estradiol cream 0.01% (0.1 mg/gram) Fasenra syringe 30mg/mL T5 PA (FASENRA) fluticasone-salmeterol aerosol powder 113- T1 QL (60 PER 30 breath activated 14mcg/actuation fluticasone-salmeterol aerosol powder 232- T1 QL (60 PER 30 breath activated 14mcg/actuation fluticasone-salmeterol aerosol powder 55- T1 QL (60 PER 30 breath activated 14mcg/actuation Herceptin recon soln 150mg T5 PA (B VS D) Kurvelo tablet mg levonorgestrel-ethinyl tablet mg estradiol medroxyprogesterone syringe 150mg/mL Roweepra tablet 750mg Roweepra tablet 500mg Selzentry solution 20mg/mL T3 Shingrix (PF) suspension for 50mcg/0.5 ml T3 reconstitution Tamiflu capsule 75mg T3 Tamiflu capsule 30mg T3 Tamiflu capsule 45mg T3 tenofovir disoproxil tablet 300mg T5 fumarate Xigduo XR tablet, IR - ER, 2.5-1,000mg T3 QL (60 PER 30 biphasic 24hr Zenpep capsule,delayed 40, ,000- T5 release(dr/ec) 168,000 unit abacavir solution 20mg/mL Biktarvy tablet mg T5 Digox tablet 250mcg Digox tablet 125mcg efavirenz capsule 200mg T5 efavirenz tablet 600mg T5 7
8 Erleada tablet 60mg T5 (ERLEADA) haloperidol lactate syringe 5mg/mL isotretinoin capsule 10mg isotretinoin capsule 20mg isotretinoin capsule 40mg isotretinoin capsule 30mg Levonorgestrel/ethinyl estradiol-ethinyl estradiol tablets,dose pack,3 month 0.10 mg-20 mcg(84)/10 mcg (7) memantine capsule,sprinkle,er 24hr 14mg PA (MEMANTINE) memantine capsule,sprinkle,er 21mg PA (MEMANTINE) 24hr memantine capsule,sprinkle,er 28mg PA (MEMANTINE) 24hr memantine capsule,sprinkle,er 7mg PA (MEMANTINE) 24hr methotrexate sodium solution (INJ) 25mg/mL PA (B VS D) minocycline tablet extended release 24 hr 115mg T5 minocycline tablet extended 65mg T5 release 24 hr naloxone syringe 0.4mg/mL Natroba suspension 0.9% T3 Nolix cream 0.05% Qvar RediHaler HFA aerosol breath activated 80mcg/actuation T3 Qvar RediHaler HFA aerosol breath 40mcg/actuation T3 activated sodium tablet 500mg T5 phenylbutyrate sumatriptan-naproxen tablet mg Symdeko tablets, sequential mg T5 (d)/150 mg (n) Symproic tablet 0.2mg T3 trientine capsule 250mg T5 PA (SYPRINE) Videx EC capsule,delayed release(dr/ec) 125mg 8 T4 QL (56 PER 28 ; PA (SYMDEKO)
9 Zenpep capsule,delayed 25,000-79,000- T3 release(dr/ec) 105,000 unit Zenpep capsule,delayed 5,000-17,000- T3 release(dr/ec) 24,000 unit Abilify Maintena suspension,extended 400mg T5 rel recon Alimta recon soln 100mg T5 PA (B VS D) Daliresp tablet 250mcg T4 PA (DALIRESP) Fabrazyme recon soln 5mg T5 Glatopa syringe 40mg/mL T5 QL (12 PER 28 ; PA (COPAXONE) Haegarda recon soln 2,000unit T5 PA (C1 ESTERASE INHIBITORS); LA Haegarda recon soln 3,000unit T5 PA (C1 ESTERASE INHIBITORS); LA hydrocortisonepramoxine cream 1-1% IBU tablet 600mg T1 IBU tablet 800mg T1 Ilaris (PF) solution 150mg/mL T5 PA (ILARIS); LA Imbruvica capsule 70mg T5 QL (240 PER 30 ; New Starts Only PA (IMBRUVICA) Imbruvica tablet 140mg T5 QL (120 PER 30 ; New Starts Only PA (IMBRUVICA) Imbruvica tablet 280mg T5 QL (60 PER 30 ; (IMBRUVICA) Imbruvica tablet 420mg T5 QL (40 PER 30 ; (IMBRUVICA) Imbruvica tablet 560mg T5 QL (30 PER 30 ; (IMBRUVICA) Intron A solution 10 T3 PA (B VS D) millionunit/ml Isentress HD tablet 600mg T5 Kelnor 1-50 tablet 1-50mg-mcg lamotrigine tablets,dose pack 25mg (35) 9
10 lamotrigine tablets,dose pack 25 mg (42)-100 mg (7) lamotrigine tablets,dose pack 25 mg (84)-100 mg (14) levoleucovorin recon soln 50mg T5 Melodetta 24 Fe tablet,chewable 1 mg-20 mcg(24)/ 75 mg (4) Orfadin capsule 20mg T5 Ozempic pen injector 0.25 mg or 0.5mg(2 mg/1.5 T3 PA (GLUCAGON-LIKE PEPTIDE-1 ml) AGONISTS) Ozempic pen injector 1 mg/0.75 ml(2 mg/1.5 ml) palonosetron solution 0.25mg/5 ml Plegridy syringe 63 mcg/0.5 ml- T5 94 mcg/0.5 ml ritonavir tablet 100mg T3 PA (GLUCAGON-LIKE PEPTIDE-1 AGONISTS) QL (1 PER 180 ; PA (PLEGRIDY) Rubraca tablet 250mg T5 QL (150 PER 30 ; New Starts Only PA (rubraca); LA Sylvant recon soln 400mg T5 PA (B VS D) Symfi Lo tablet mg T5 Synagis solution 100mg/mL T5 LA tiagabine tablet 12mg tiagabine tablet 16mg triamcinolone acetonide suspension 40mg/mL Tydemy tablet mg (21) (7) Viramune suspension 50mg/5 ml T4 Zytiga tablet 500mg T5 QL (60 PER 30 ; (ZYTIGA) 10
11 Deletions Drug Name Dosage Dosage Form Reason for Change Alternative Drug Alternative Drug Tier Effective Date No deletions No deletions No deletions No deletions Please consult with your physician to determine if the alternative drug listed here is appropriate for you. If you have any questions regarding the BlueShield of Northeastern New York Medicare Part D formulary, please contact the customer service number on the back of your member ID card. Changes from Previous Month s Formulary Drug Name Dosage Form Strength Previous Tier & Limitations Current Tier & Limitations Effective Date buprenorphine HCl tablet 2mg ; QL (100 PER 30 buprenorphine HCl tablet 8mg ; QL (25 PER 30 Enbrel recon soln 25mg (1 ml) T5; QL (16 PER 28 T5; QL (8 PER 28 ; PA (ENBREL) ; PA (ENBREL) hydrocodoneacetaminophen tablet mg ; QL (360 PER 30 ; QL (390 PER 30 hydrocodoneacetaminophen tablet 5-300mg ; QL (360 PER 30 ; QL (390 PER 30 hydrocodoneacetaminophen tablet mg ; QL (360 PER 30 ; QL (390 PER 30 leuprolide kit 1mg/0.2 ml ; PA (B VS D) megestrol suspension 625mg/5 ml T4; PA (MEGACE) ; PA (MEGACE) megestrol tablet 20mg T4; New Starts Only PA (MEGACE) ; New Starts Only PA (MEGACE) megestrol tablet 40mg T4; New Starts Only PA (MEGACE) ; New Starts Only PA (MEGACE) megestrol suspension 400 mg/10 ml(40 mg/ml) T4; PA (MEGACE) ; PA (MEGACE) valacyclovir tablet 1gram ; QL (30 PER 30 ; QL (120 PER 30 11
12 Changes from Previous Month s Formulary Drug Name Dosage Form Strength Previous Tier & Limitations valacyclovir tablet 500mg ; QL (30 PER 30 Vicodin tablet 5-300mg ; QL (360 PER 30 Vicodin ES tablet mg ; QL (360 PER 30 Vicodin HP tablet mg ; QL (360 PER 30 No changes tiagabine tablet 2mg T4 tiagabine tablet 4mg T4 No changes Current Tier & Limitations Effective Date ; QL (60 PER 30 ; QL (390 PER 30 ; QL (390 PER 30 ; QL (390 PER 30 BlueShield of Northeastern New York is a Medicare Advantage plan with a Medicare contract and enrollment depends on contract renewal. A division of HealthNow New York Inc., an independent licensee of the BlueCross BlueShield Association. The formulary may change at any time. You will receive notice when necessary. 12
2018 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This
More informationDuring non-business hours, your call will be answered by our automated phone system. A representative will return your call the next business day.
MEICARE AVANTAGE BlueCross BlueShield of Western New York 2018 Formulary Update BlueCross BlueShield of Western New York has updated its formulary (drug list) since its original publication in January
More information2018 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January. This document
More informationYou ll find the most up-to-date comprehensive version of our formulary on our website, Click on Drug Finder.
3/1/2018 Medicare Part D Formulary Change In an effort to cover the most needed, cost-effective prescriptions, the AlohaCare Advantage Plus (HMO SNP) Formulary is updated monthly. The following are drugs
More information2018 Medicare Part D Formulary Change
2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
More information2018 Medicare Part D Formulary Change
2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
More informationHealth Partners Medicare Special 2018 Formulary Changes
Health Partners Medicare Special 2018 Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes available.
More informationNOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF CHANGES The following summary describes changes to the 2018 Presbyterian Senior Care (HMO)/(HMO-POS), Presbyterian MediCare PPO and formularies. The formulary may change at any time. You
More information2019 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January. This document
More informationSuperior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum
Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum Below is a list formulary changes for the benefit year 2018. This is not a complete list of drugs covered by the Part D plan. The
More informationHealth Partners Medicare Special Formulary Updates
March 2018 Effective Date Brand Name Generic Name Type of Change 90 / 30 DAYS tenofovir disoproxil fumarate tenofovir disoproxil fumarate clobetasol propionate tenofovir disoproxil fumarate Previous Value
More informationUPHP Advantage (HMO) (H ) and UPHP Choice (HMO) (H ) Updates
March, 2018 03/01/2018 clindacin p clindamycin phosphate 03/01/2018 glatiramer acetate 03/01/2018 glatiramer acetate 03/01/2018 oseltamivir phosphate 03/01/2018 oseltamivir phosphate 03/01/2018 ADACEL
More informationBlue Shield 65 Plus Choice Plan (HMO) Blue Shield of California is an independent member of the Blue Shield Association. Formulary Updates:
Blue Shield 65 Plus Choice Plan (HMO) Formulary Updates: The enclosed table lists the changes made to your formulary such as removing or adding: a drug, prior authorization, quantity limits or step therapy
More informationChanges to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies
Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies BlueCross BlueShield of South Carolina may add or remove drugs from the formulary during the year. If we remove drugs
More information2018 CareOregon Advantage Part D Formulary Changes
2018 CareOregon Advantage Part D Formulary Changes Abbreviations: AGE = Age Restriction; PA = Prior Authorization Required; QL = Quantity Limit; ST = Step Therapy Required; LD = Limited Distribution; BvD
More informationUpper Peninsula MI Health Link Updates
January, 2018 01/01/2018 TAMIFLU oseltamivir phosphate CHANGE UM: QUANTITY 720 / 365 days 720 / 365 OVER 01/01/2018 oseltamivir phosphate 01/01/2018 oseltamivir phosphate 01/01/2018 oseltamivir phosphate
More information2018 Formulary Notice of Change Prescription Drug Plans
2018 Formulary Notice of Change Prescription Drug Plans WellCare Prescription Insurance, Inc. Plans in all states: WellCare Classic (PDP) WellCare may add or remove drugs from our formulary during the
More informationHAP/Midwest Health Advantage MI Health Link (MMP) Updates
January, 2018 01/01/2018 hydrocortisone butyrate hydrocortisone butyrate 01/01/2018 MIRVASO brimonidine tartrate 01/01/2018 AZACTAM aztreonam 01/01/2018 AZACTAM aztreonam 01/01/2018 mesalamine mesalamine
More informationBlue Cross and Blue Shield of Minnesota GenRx Formulary Updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates July 2018 TRADE NAME (generic name) or generic name ADVAIR DISKUS (fluticasone-salmeterol aer powder ba 100-50 mcg/dose) Brand Addition ADVAIR
More informationBlue Shield Rx Enhanced (PDP) Formulary Updates:
Blue Shield Rx Enhanced (PDP) Formulary Updates: The enclosed table lists the changes made to your such as removing or adding: a drug, prior authorization, quantity limits or step therapy as well as any
More informationBlue Shield 65 Plus (HMO) Formulary Updates:
Blue Shield 65 Plus (HMO) Updates: The enclosed table lists the changes made to your such as removing or adding: a drug, prior authorization, quantity limits or step therapy as well as any changes to a
More informationReason for change. Recently approved. Recently approved. Recently approved. Recently approved. Recently updated. Recently approved.
2017 Formulary Change Notice Please note these changes to your 2017 List of Covered Drugs Drug name (medication) Rubraca Aprepitant Onivyde Oseltamivir Restasis Xiidra Daptomycin Selzentry Linzess Butalb/APAP/caff
More informationMemorial Hermann Advantage HMO February 2019 Formulary Addendum
Memorial Hermann Advantage HMO February 2019 Formulary Addendum Changes may have occurred since the printing of your current Memorial Hermann Advantage HMO Formulary. Medications that may have been added
More information2017 Formulary Addendum Notice of Change (Prescription Drug Plans)
2017 Formulary Addendum Notice of Change (Prescription Drug Plans) WellCare Prescription Insurance, Inc. WellCare Classic (PDP) WellCare Extra (PDP) This is a listing of the changes that have occurred
More information2017 Medicare Part D Formulary Change
2017 Medicare Part D Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy restrictions
More informationPRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand
More informationPRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand
More information2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)
207 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Plus Plan (HMO) H5087-002, H5087-07 This is a listing of the changes that have occurred in our formulary.
More information2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)
2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Best Plan (HMO) H5087-005 This is a listing of the changes that have occurred in our formulary. Please
More informationQuarterly pharmacy formulary change notice
Provider update Quarterly pharmacy formulary change notice Summary: The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018, Pharmacy and Therapeutics Committee
More information2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)
2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Freedom Plan (HMO SNP) H5087-001 This is a listing of the changes that have occurred in our formulary.
More information2018 OPEN FORMULARY Updates
January, 2018 01/01/2018 OPDIVO nivolumab 01/01/2018 KEVZARA sarilumab 01/01/2018 KEVZARA sarilumab 01/01/2018 AIMOVIG AUTOINJECTOR,AIMOVIG AUTOINJECTOR (2 PACK) erenumab-aooe 01/02/2018 glucose in water
More information2017 Formulary Addendum Notice of Change
017 Formulary Addendum Notice of Change (Medicare Advantage Plans) WellCare Health Plans WellCare Choice (HMO), WellCare Essential (HMO-POS), WellCare Value (HMO) This is a listing of the changes that
More information2017 Medicare Part D Formulary Change
2017 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
More informationPartners Notice of Change March 2017
New Added Products: Effective 3/1/2017 Drug Reason Tier Restrictions abacavir 600 mg-lamivudine 300 QL ADRENACLICK 0.15 MG/0.15 ML INJECTION,AUTO- INJECTOR ADRENACLICK 0.3 MG/0.3 ML INJECTION, AUTO- INJECTOR
More information2017 Formulary Addendum Notice of Change
2017 Formulary Addendum Notice of Change (Prescription Drug Plans) WellCare Prescription Insurance, Inc. WellCare Classic (PDP) WellCare Extra (PDP) This is a listing of the changes that have occurred
More information2017 Formulary Addendum Notice of Change
2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) WellCare Health Plans WellCare Access (HMO SNP), WellCare Liberty (HMO SNP), WellCare Reserve (HMO), WellCare Rx (HMO), WellCare Select
More informationAetna Better Health of Illinois Medicaid Formulary Updates
October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary
More informationFormulary Change Notice
Formulary Change Notice HealthPartners may remove drugs from our formulary (list of covered drugs) or add rules about whether and when certain drugs are covered during the year. The chart below contains
More informationQuarterly pharmacy formulary change
Medi-Cal Managed Care L. A. Care Major Risk Medical Insurance Program Provider Bulletin The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018 Pharmacy and
More information5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details
5-ASA DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum. 1 ANTIEMETICS
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Provider update Summary: Effective August 1, 2018, the preferred formulary changes detailed in the table below will apply to District of Columbia Healthy Families
More information5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release
Updated 11/1/17 5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda
More information2018 Step Therapy Criteria (List of Step Therapy Criteria)
Criteria Last Updated: October 05, 2017 Effective Date: January 1, 2018 2018 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP DUALCHOICE CAL MEDICONNECT PLAN (MEDICARE-
More informationStep Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 05/01/2018 Updated 4/2018 H0302_2_2014 CMS Accepted 05/05/2014 1 BETA-BLOCKERS BYSTOLIC 10 MG
More information2018 Step Therapy Criteria (List of Step Therapy Criteria)
Step Therapy Criteria Last Updated: March 20, 2018 Effective Date: April 1, 2018 2018 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP DUALCHOICE CAL MEDICONNECT PLAN (MEDICARE-MEDICAID
More informationHealth Partners Medicare Prime 2019 Formulary Changes
Health Partners Medicare Prime 2019 Formulary Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes
More informationWellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum
WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum This is a listing of the changes that have occurred in our formulary. Please carefully review these changes and call WellCare if you
More information2017 Medicare Part D Formulary Change
2017 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
More informationStep Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 12/01/2017 Updated 11/2017 H0302_2_2014 CMS Accepted 05/05/2014 1 ABILIFY Abilify 10 mg tablet
More informationQuarterly pharmacy formulary change notice
Provider Bulletin April 2018 This table is used by HealthKeepers, Inc. to indicate formulary changes applicable to all Anthem HealthKeepers Plus members. These changes were reviewed and approved at the
More informationEmblem Medicaid 3Q18 Formulary Updates
ALKERAN 2 MG TABLET Removed from Formulary 7/9/2018 AMITIZA 24 MCG CAPSULES Removed from Formulary 7/9/2018 AMITIZA 8 MCG CAPSULE Removed from Formulary 7/9/2018 avo cream topical emulsion Removed from
More informationICP Formulary Updates
ICP Formulary Updates July 2017 TRADE NAME (generic name) adapalene cream 0.1% 2017-07-01 Removal adapalene gel 0.3% 2017-07-01 Removal adefovir dipivoxil tab 10 mg 2017-07-01 Removal ADVAIR DISKUS (fluticasone-salmeterol
More informationJANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.
ANTI DIABETICS BYDUREON 2 MG SUBCUTANEOUS JANUVIA 25 MG TABLET EXTENDED RELEASE SUSPENSION JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET
More informationUpdates to your prescription benefits
Updates to your prescription benefits Effective January 1, 2019 Update Summary Within the Prescription Drug List (PDL), medications are grouped by tier. The tier indicates the amount you pay when you fill
More informationPresbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. NOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the Presbyterian Commercial Large Group Plans (Non-Metal Plans) Formularies effective 2018. For the most recent list of drugs,
More information2016 Step Therapy (ST) Criteria
2016 Step Therapy (ST) Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a drug that
More informationHEALTH SHARE/PROVIDENCE (OHP)
HEALTH SHARE/PROVIDENCE (OHP) STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered
More information2014 Step Therapy Criteria (List of Step Therapy Criteria)
Criteria Last Updated: November 1, 2014 2014 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP MEDICARE DUALCHOICE (HMO SNP) REQUIRES YOU TO FIRST TRY CERTAIN DRUGS TO TREAT
More information2016 FORMULARY ADDENDUM NOTICE OF CHANGE
2016 FORMULARY ADDENDUM NOTICE OF CHANGE (PRESCRIPTION DRUG PLANS) WELLCARE PRESCRIPTION INSURANCE, INC. WellCare Simple (PDP) WellCare Classic (PDP) WellCare Extra (PDP) This is a listing of the changes
More information2019 Drug List Negative Changes
2019 Drug List Negative Changes Updated 03/26/2019 If you are taking a drug that is removed from the formulary (also known as the Drug List), we will tell you. We will also tell you if we add any restrictions
More informationFORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
More informationBlueLink TPA FlexRx Updates
BlueLink TPA FlexRx Updates April 2018 TRADE NAME (generic name) or generic name abacavir sulfate soln 20 mg/ml (base equiv) Generic Addition, generic for ZIAGEN alclometasone dipropionate cream 0.05%
More informationPresbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. NOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the 2017 Presbyterian Individual and Family Metal Plan/Employer Group Metal Plan Formularies effective 2018. For the most recent
More informationUpdates to your prescription benefits
Updates to your prescription benefits Effective Jan. 1, 2019 Traditional Three-Tier PDL Update Summary Within the Prescription Drug List (PDL), medications are grouped by tier. The tier indicates the amount
More informationDrug Name Description of Change Formulary Coverage Formulary Alternative(s)
NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the Presbyterian Centennial Care Formulary effective 2018. For the most recent list of drugs, information on asking for a prior
More informationPRESCRIPTION DRUG PROGRAM FORMULARY UPDATES
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Generic Additions These generic drugs recently became available in the marketplace. When these generic drugs became available, we began covering them at the
More informationQuarterly pharmacy formulary change notice
Provider Bulletin October 2018 Quarterly pharmacy formulary change notice The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus patients. The changes listed in the table
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at our second quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October
More information2017 Step Therapy Criteria
FRESENIUS TOTAL HEALTH 2017 Step Therapy Updated 07/01/2017. For more recent information or other questions, please contact Fresenius Total Health Customer Service at 1-855-598-6774 / TTY 1-844-209-9094.
More information2017 Medicare Part D Formulary Change
2017 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
More informationStep Therapy Requirements. Effective: 11/01/2018
Effective: 11/01/2018 Updated 10/2018 ANTIDEPRESSANTS Sharp Health Plan (HMO) TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK
More informationFORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
More informationALLERGIC CONJUNCTIVITIS AGENTS
2018 5 Tier Standard- Keystone First VIP Choice Document: 2018 Step Therapy Formulary ID: 18390 Last Updated: 04/2018 Effective Date: 05-01-2018 ALLERGIC CONJUNCTIVITIS AGENTS epinastine 0.05 % eye drops
More information2019 Drug List Negative Changes
2019 Drug List Negative Changes Updated 03/26/2019 If you are taking a drug that is removed from the formulary (also known as the Drug List), we will tell you. We will also tell you if we add any restrictions
More information2018 Step Therapy (ST) Criteria
2018 Step Therapy (ST) Criteria Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a
More information2014 Quantity Limits (QL) Criteria
2014 Quantity Limits (QL) Criteria Certain drugs covered through your EmblemHealth Medicare HMO/PPO Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food
More informationUpdates to your prescription benefits
Updates to your prescription benefits Effective July 1, 2018 Update Summary Within the Prescription Drug List (PDL), medications are grouped by tier. The tier indicates the amount you pay when you fill
More informationDrugs That Require Step Therapy (ST) Step Therapy Medications
Drugs That Require Step Therapy (ST) In some cases, BlueShield of Northeastern New York requires you to first try certain drugs to treat your medical condition before we will cover another drug for that
More informationACYCLOVIR OINT (CCHP2017)
ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN
More informationMedicare Part D 2016 Formulary Changes Service To Senior and OC Preferred
Medicare Part D 2016 Formulary s Service To Senior and OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior
More informationQuarterly pharmacy formulary change notice
MEDICAID PROVIDER BULLETIN October 2018 The formulary changes listed in the table below were reviewed and approved at the second-quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October
More informationANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria
ANTIDEPRESSANTS Trintellix 10 mg tablet Trintellix 20 mg tablet Trintellix 5 mg tablet Viibryd 10 mg (7)-20 mg (23) tablets in a dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet
More informationAcyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria
Medications that require Step Therapy (ST) require trial and failure of preferred formulary agents prior to their authorization. If the prerequisite medications have been filled within the specified time
More information2017 Formulary Changes Year to Date
2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Provider update Summary: The formulary changes listed in the table below were reviewed and approved at our second quarter 2018, Pharmacy and Therapeutics Committee
More informationNotice of Mid-Year Changes to 2019 Paramount Enhanced Formulary
Notice of Mid-Year s to 2019 Paramount Enhanced Formulary Paramount Elite (HMO) may immediately remove a brand name drug on our List if we are replacing it with a new generic drug that will appear on the
More informationMercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir
Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1 Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2 Albenza ALBENZA TABLET 200 MG ORAL Requires
More informationBlue Cross and Blue Shield of Minnesota GenRx Formulary Updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates April 2018 TRADE NAME (generic name) or generic name Brand/Generic Description of Change abacavir sulfate soln 20 mg/ml (base equiv) Generic
More informationALPHA BLOCKERS. Products Affected Step 1: Details. Step 2: Rapaflo 4 mg capsule Rapaflo 8 mg capsule
CHRISTUS Health Plan Generations (HMO) CHRISTUS Health Plan Generations Plus (HMO) 2018 Premier Performance Standard Step Therapy PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT SOME OF THE DRUGS
More information5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release
5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum.
More informationStep Therapy Requirements. Effective: 05/01/2018
Step Therapy Requirements Effective: 05/01/2018 ANTIDEPRESSANTS TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK VIIBRYD 10 MG
More informationDrugs That Require Step Therapy (ST) Step Therapy Medications
Drugs That Require Step Therapy (ST) In some cases, BlueCross BlueShield of WNY requires you to first try certain drugs to treat your medical condition before we will cover another drug for that condition.
More informationUpdates to your prescription benefits
Updates to your prescription benefits Effective July 1, 2018 Update Summary Within the Prescription Drug List (PDL), medications are grouped by tier. The tier indicates the amount you pay when you fill
More informationAetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates
Aetna Better Health Illinois Premier Plan November 2015 Formulary Updates desogestrel & ethinyl estradiol tab 0.15 mg-30 mcg RIVASTIGMINE DIS 13.3/24; QL (30 patches/30 days) RIVASTIGMINE DIS 4.6MG/24;
More informationNetwork Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary
Requesting an Exception to the Formulary You can ask Network Health Insurance Corporation to make an exception to our coverage rules. Generally, we will only approve your request for an exception if alternative
More informationYour prescription benefit updates Formulary Updates - Effective January 1, 2019
Your prescription benefit updates Formulary Updates - Effective January 1, 2019 Medications are grouped by the conditions they treat. Each medication is placed in a tier that shows the amount you will
More information